AI-Identified Reasons for Nonescalation of Lipid-Lowering Therapy for Secondary Prevention.

Somani S, Kim DD, Ramaraju V, Ngo S, Babu C, Bouladian S, Chen T, King S, Perez-Guerrero E, Ronaghi S, Hwang J, Maron DJ, Hernandez-Boussard T, Alsentzer E, Rodriguez F

Open source

DOI: 10.1001/jamacardio.2026.5230
Published: 2026 Nov 7
Container: JAMA cardiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamacardio.2026.5230,
  title = {AI-Identified Reasons for Nonescalation of Lipid-Lowering Therapy for Secondary Prevention.},
  author = {Somani S and Kim DD and Ramaraju V and Ngo S and Babu C and Bouladian S and Chen T and King S and Perez-Guerrero E and Ronaghi S and Hwang J and Maron DJ and Hernandez-Boussard T and Alsentzer E and Rodriguez F},
  year = {2026},
  journal = {JAMA cardiology},
  doi = {10.1001/jamacardio.2026.5230},
  url = {https://doi.org/10.1001/jamacardio.2026.5230}
}

RIS

TY  - JOUR
TI  - AI-Identified Reasons for Nonescalation of Lipid-Lowering Therapy for Secondary Prevention.
AU  - Somani S
AU  - Kim DD
AU  - Ramaraju V
AU  - Ngo S
AU  - Babu C
AU  - Bouladian S
AU  - Chen T
AU  - King S
AU  - Perez-Guerrero E
AU  - Ronaghi S
AU  - Hwang J
AU  - Maron DJ
AU  - Hernandez-Boussard T
AU  - Alsentzer E
AU  - Rodriguez F
PY  - 2026
JO  - JAMA cardiology
DO  - 10.1001/jamacardio.2026.5230
UR  - https://doi.org/10.1001/jamacardio.2026.5230
ER  -

APA

S, S., DD, K., V, R., S, N., C, B., S, B., T, C., S, K., E, P., S, R., J, H., DJ, M., T, H., E, A., & F, R. (2026). AI-Identified Reasons for Nonescalation of Lipid-Lowering Therapy for Secondary Prevention.. JAMA cardiology. https://doi.org/10.1001/jamacardio.2026.5230

Source records

pubmed · retrieved 2026-11-10T12:36:11.300Z
europe-pmc · retrieved 2026-11-10T12:36:11.305Z